Following a government consultation, updated guidance on the application and implications of Intellectual Property (IP) restrictions has been published. Essentially there is no change to the rules that were established following Brexit, but it is important for businesses who participate in this trading style are aware of the rules.
At various points over the last few years we have heard the cry of ‘let’s just get Brexit done’. Given that it is over 8 years since the public vote, it would be good to think we are somewhere near closing out the loose ends.
Given the complexity of storing some modern medicines; either because of unusual storage requirements, because of the value of the product or simply because of space considerations, what can a pharmacy do?
Given all the recent attention that has rightly been placed on the upcoming changes to medicinal products for the UK market, as a result of the implementation of parts of the Windsor Framework, it would be easy to assume that similar changes or at least thought processes would apply to other products.
In good news for the UK Health economy, the Government last week published a draft policy to allow medical devices and IVDs that have been approved in certain other countries quicker access to the UK market.
